XERS filings
Corporate insider profile
Dawn Halkuff Filing Activity
Latest reported as Corporate insider of Xeris Biopharma Holdings, Inc. (XERS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$121,886.00
- Latest transaction
- Jun 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
